Speaker illustration

Mr Sake van der Wall

Leiden University Medical Centre, Leiden (Netherlands (The))

Evaluation of appropriate use and clinical outcomes of idarucizumab as antidote of dabigatran in daily clinical practice

Event: ESC Congress 2018

Topic: Oral Anticoagulation

Session: Atrial fibrillation - Stroke prevention

Thumbnail

This platform is supported by

logo Novo Nordisk